COO Q3 Earnings Beat, 2025 Sales Outlook Lowered, Stock Down

The Cooper Companies (COO) reported mixed fiscal Q3 2025 results, with adjusted EPS of $1.10 beating estimates by 2.8% due to operational improvements, but revenues of $1.06 billion, up 6% year-over-year, narrowly missed expectations, primarily due to weakness in Clariti sales in Asia Pacific. Despite a 100 basis point expansion in adjusted gross margin to 67%, the company lowered its fiscal 2025 revenue outlook to $4.076-$4.096 billion while simultaneously raising its adjusted EPS guidance to $4.08-$4.12. Following these results, COO's stock declined 12.9%, reflecting investor concern over the reduced sales forecast, even as the company highlighted strong performance in key product lines and ongoing operational efficiencies.

Analysis

The Cooper Companies (COO) reported a mixed fiscal third-quarter for 2025, characterized by a bottom-line beat but a top-line miss and a downward revision of its full-year revenue outlook, which prompted a significant negative market reaction. While adjusted EPS grew 15% year-over-year to $1.10, beating consensus estimates, total revenues of $1.06 billion missed expectations and showed decelerating organic growth of just 2%. The stock's subsequent 12.9% decline underscores investor focus on the weakened revenue forecast, now set at $4.076-$4.096 billion, over the company's improved profitability. The primary source of weakness was the CooperVision (CVI) segment, where sales of the Clariti product line and softness in Asia Pacific e-commerce channels led to a 5% organic revenue decline in that region. This softness overshadowed strong performance from high-margin products like MyDAY and MiSight, which grew at double-digit rates. Operationally, the company demonstrated strong execution by expanding its adjusted gross margin by 100 basis points to 67%, enabling it to raise its full-year adjusted EPS guidance to a range of $4.08-$4.12. However, this profitability gain was not enough to assuage concerns about the slowing top-line and the stock's substantial year-to-date underperformance of -29.8% compared to the industry's -1.7% decline.

Key Decisions for Investors

• Given the lowered revenue guidance and sharp 12.9% stock drop, investors should exercise caution and closely monitor for signs of stabilization in the CooperVision segment, particularly in the struggling Asia Pacific market.
• The divergence between a lowered sales forecast and a raised EPS outlook warrants attention; investors should assess if the margin expansion from operational efficiencies and high-value products is sustainable enough to justify holding through the current top-line weakness.
• Considering the stock's significant underperformance of nearly 30% year-to-date, a relative value analysis against peers demonstrating more robust growth may be warranted before initiating or adding to a position.